Dados B3 › GFSA3 × RAIZ4
GFSA3 × RAIZ4
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | GFSA3 | RAIZ4 | year |
|---|---|---|---|
| ROE | -31.2% | -21.8% | 2025 |
| ROIC | -8.4%! | 4.8%! | 2025 |
| ROA | -10.9% | -3.1% | 2025 |
| Gross margin | -32.1% | 4.6% | 2025 |
| EBIT margin | -66.9% | 1.7% | 2025 |
| Net margin | -87.9% | -1.6% | 2025 |
| Net debt/EBITDA | 4.13x | 1.63x | 2021 |
| Current ratio | 1.25x | 1.33x | 2025 |
| Revenue growth (1y) | -38.8% | 15.8% | 2025 |
| Revenue growth (5y CAGR) | -6.9% | 20.4% | 2025 |
| Piotroski F-Score | 2/9 | 5/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | GFSA3 | RAIZ4 | year |
|---|---|---|---|
| P/E | -3.36x | -0.15x | 2024 × 2026 |
| P/B | 0.07x | — | 2024 × 2026 |
| EV/EBITDA | — | 37.95x | 2024 × 2026 |
| FCF yield | 109.2% | -245.9% | 2024 × 2026 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:14 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:14 UTC. If this does not match /saude, you are reading a cached copy.